Today, we would like to share some exciting news with you.
We just launched three new full-spectrum CBD oils with a high concentration of three increasingly popular minor cannabinoids - CBG, CBN and CBC.
At the time of this announcement, the products were available to order.
Full Spectrum CBG+CBD tincture
The 10 ml bottle contains 1% CBG (100 mg), 3% CBD (300 mg) and a full spectrum of cannabinoids with less than 0.2% THC diluted in organic MCT oil.
What is CBG?
Cannabigerol is one of the better-known cannabinoids after CBD and THC - and an important one. In the hemp plant, THC and CBD are made from CBGA, the acid form of CBG: the plant converts CBGA into THCA and CBDA, which become THC and CBD.
Some cannabis breeders grow strains with higher amounts of CBG because of growing interest in the cannabinoid.
Why use CBG?
Laboratory and animal studies suggest that CBG can relax blood vessels and may have neuroprotective effects, for example in mouse models of Huntington’s disease. In studies in cats, CBG applied to the eyes lowered intraocular pressure, which led researchers to suggest it may have potential for glaucoma, but this has not been shown in people.
Early research has explored CBG in relation to inflammation, colon disorders such as experimental colitis in mice, bladder contractions in laboratory tests, Huntington’s disease models and abnormal cell growth. These potential uses, and others that have been suggested such as irritable bowel and thyroid conditions, have not been established in human studies.
In laboratory and mouse studies of colon cancer, CBG blocked the TRPM8 receptor and inhibited the growth of cancer cells, but it has not been shown to treat cancer in people. Read more about CBG.
Full Spectrum CBN+CBD tincture
The 10 ml bottle contains 1% CBN (100 mg), 3% CBD (300 mg) and a full spectrum of cannabinoids with less than 0.2% THC diluted in organic MCT oil.
Why Cannabinol (CBN)?
In short, this cannabinoid has attracted interest in relation to appetite, severe pain, sleep, CNS disorders, neuro-inflammatory disorders and fibrosis, although none of these uses is established. Laboratory research has reported antibacterial activity, including against MRSA, and possible pain-relieving and anti-inflammatory effects, but a 2021 review found insufficient evidence to support claims that CBN promotes sleep.
We just published a very detailed article about CBN that we recommend you read.
Full Spectrum CBC+CBD tincture
The 10 ml bottle contains 1% CBC (100 mg), 4% CBD (400 mg) and a full spectrum of cannabinoids with less than 0.2% THC diluted in organic MCT oil.
Why Cannabichromene (CBC)?
Although CBC has not been proven to have a direct pain-relieving effect on its own, the cannabinoid has another characteristic: its comprehensive pharmacological properties.
Scientists tested the cannabinoid and its substances for their possible anti-inflammatory and antibacterial effects in the early 1980s. In those laboratory tests, CBC showed strong antibacterial and mild to moderate antifungal activity, and a 2008 laboratory study found that CBC and other major cannabinoids were active against antibiotic-resistant MRSA strains. These findings do not show that CBC works as an antibiotic in people.
CBC has also been studied in relation to gastrointestinal and gut health: in mice, it reduced inflammation-induced intestinal hypermotility. Its potential for postoperative pain, Crohn’s Disease or overall gut health has not been established.
We also just published a very detailed article about CBC that we recommend you read as well.